SESSION TITLE: Tuesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM PURPOSE: This is a retrospective analysis which determine the need of ROSE along with EBUS TBNA in improving diagnostic yield of mediastinal lymph node sampling. METHODS: At our centre when EBUS was introduced, diagnostic yield was lower than other international centers. Among the 25 cases Pre ROSE, 6(24%) of samples were unsatisfactory and hence non diagnostic. Hence we introduced ROSE for EBUS mediastinal lymph node sampling with the intention to improve the diagnostic yield and reduce unsatisfactory samples by 50%. This Quality improvement study was conducted at the Bronchoscopy suite of Hamad General Hospital. The intervention was to perform ROSE on all diagnostic samples by a cytologist at every nodal sampling. The nodal sampling is continued until confirmation of adequate diagnostic material. A representative sample of the pre ROSE over 6 months in 2016 was compared to the representative sample of Post ROSE over 6 months in 2018. RESULTS: EBUS was performed on 25 patients before ROSE. The diagnosis was obtained in 12 (48%) of the patients. (Table1) Following the introduction of ROSE, there was a statistically significant increase in diagnosis 21(84%) of the 25 patients (P 0.018) (Fig 1). This resulted in a relative increase of 175% of diagnosis. Pre ROSE sampling was non-diagnostic in 13(52%), 6 (24%) was unsatisfactory samples and 7(28%) were nodal sampling but inadequate for diagnosis. Post Rose sampling was non-diagnostic in only 4 (16%); 1(4%) out of these were unsatisfactory and 3(12%) were nodal samples but inadequate for diagnosis (Fig 2).This resulted in a 325% relative decrease in non-diagnostic sampling. CONCLUSIONS: The utility of ROSE during EBUS-TBNA has been reported in literature. There had been conflicting results up to date. However, a high concordance rate is reported in a recent study (4). Our study has demonstrated that the introduction of ROSE has resulted in improved diagnostic yield of EBUS TBNA. This would also translate into lesser number of invasive procedures like mediastinoscopy required for the nondiagnostic EBUS TBNA sampling. Given our findings ROSE during EBUS TBNA is our new standard of care at Hamad General Hospital. We would therefore recommend that ROSE should be the standard of care for EBUS TBNA across HMC if the services are being expanded at other sites. A randomised prospective trial evaluating the utility of ROSE would help strengthen our conclusions and support for ROSE. The limitation of this study was that it was performed at a single institution. Therefore, generalisation to other institutions may be limited. CLINICAL IMPLICATIONS: Combining ROSE with EBUS TBNA improves diagnostic yield, reduces unsatisfactory nodal sampling and procedure time. DISCLOSURES: no disclosure on file for Hisham Abdulsattar; No relevant relationships by Mushtaq Ahmad, source=Web Response No relevant relationships by MUSTAFA AKRAM YOUSIF Al-TIKRITY, source=Web Response No relevant relationships by Abbas Alabbas, source=Web Response No relevant relationships by mohammad ali, source=Web Response No relevant relationships by Nikolaos Chantziantoniou, source=Web Response No relevant relationships by Mansoor Hameed, source=Web Response No relevant relationships by Mostafa Suhail Najim Najim, source=Web Response No relevant relationships by Merlin Thomas, source=Web Response
Read full abstract